These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12800825)

  • 21. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
    JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple nuke therapy--results after one year.
    TreatmentUpdate; 2001; 12(10):3-4. PubMed ID: 11570063
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.
    Stürmer M; Dauer B; Moesch M; Haberl A; Mueller A; Locher L; Knecht G; Hanke N; Doerr HW; Staszewski S
    Antivir Ther; 2007; 12(1):25-30. PubMed ID: 17503744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study.
    Henry K; Wallace RJ; Bellman PC; Norris D; Fisher RL; Ross LL; Liao Q; Shaefer MS;
    J Infect Dis; 2001 Feb; 183(4):571-8. PubMed ID: 11170982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [First HIV triple therapy with one tablet].
    Dtsch Med Wochenschr; 2000 Feb; 125(8):A22. PubMed ID: 10723466
    [No Abstract]   [Full Text] [Related]  

  • 26. Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.
    Keiser P; Nassar N
    Expert Opin Pharmacother; 2007 Mar; 8(4):477-83. PubMed ID: 17309342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
    Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
    [No Abstract]   [Full Text] [Related]  

  • 28. Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV.
    Stürmer M; Staszewski S; Doerr HW
    Antivir Ther; 2007; 12(5):695-703. PubMed ID: 17713153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abacavir plus lamivudine: a thymidine analogue-sparing NRTI backbone.
    Moyle GJ
    AIDS Read; 2003 Nov; 13(11):528, 533-5. PubMed ID: 14649622
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-HIV agents. Abacavir--as good as AZT?
    TreatmentUpdate; 2003 Oct; 15(6):3-4. PubMed ID: 17216861
    [No Abstract]   [Full Text] [Related]  

  • 31. Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.
    Cuzin L; Pugliese P; Bugnon F; Delpierre C; Cua E; Billaud E; Massip P; Raffi F; Dellamonica P
    HIV Med; 2005 Nov; 6(6):388-95. PubMed ID: 16268820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results.
    Katlama C; Fenske S; Gazzard B; Lazzarin A; Clumeck N; Mallolas J; Lafeuillade A; Mamet JP; Beauvais L;
    HIV Med; 2003 Apr; 4(2):79-86. PubMed ID: 12702127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen.
    Kuritzkes DR
    J Infect Dis; 2005 Dec; 192(11):1867-8. PubMed ID: 16267755
    [No Abstract]   [Full Text] [Related]  

  • 34. Triple-drug tablet approved for HIV infection.
    Thompson CA
    Am J Health Syst Pharm; 2001 Jan; 58(1):22. PubMed ID: 11194130
    [No Abstract]   [Full Text] [Related]  

  • 35. Lamivudine/zidovudine/abacavir: triple combination tablet.
    Ibbotson T; Perry CM
    Drugs; 2003; 63(11):1089-98; discussion 1099-1100. PubMed ID: 12749741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abacavir sulfate, lamivudine, and zidovudine (Trizivir).
    Porche D
    J Assoc Nurses AIDS Care; 2001; 12(6):88-90. PubMed ID: 11723917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving simplified treatment strategies for HIV infection: the role of a single-class quadruple-nucleoside/nucleotide regimen of trizivir and tenofovir.
    Mastroianni CM; d'Ettorre G; Vullo V
    Expert Opin Pharmacother; 2006 Nov; 7(16):2233-41. PubMed ID: 17059380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA approves Trizivir for HIV infection.
    AIDS Read; 2000 Dec; 10(12):701. PubMed ID: 11189737
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
    Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
    Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abacavir arm stopped in clinical trial.
    James JS
    AIDS Treat News; 2003 Apr; (390):6-7. PubMed ID: 12739475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.